Group Psychotherapy in Narcolepsy Type 1

Cantonal Hospital of St. Gallen

Status

Completed

Conditions

Narcolepsy Type 1

Treatments

Behavioral: Group psychotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05314556

2021-01324

Details and patient eligibility

About

The aim of this pilot study is to test the benefit of behavior therapy-oriented, method-integrated psychotherapy in an outpatient group setting in patients with narcolepsy type 1. Therefore we collect and evaluate initial data on its effectiveness on the disease in terms of specific symptomatology, emotion regulation, health-related quality of life, and disease processing/acceptance.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosed narcolepsy type 1 according to AASM, examined by an experienced sleep physician including history, clinical examination, polysomnographic examination (PSG) with a multiple sleep latency test (MSLT), possibly also including determination of HLA DQB1 * 062 and orexin A / hypocretin 1
Age between 18 and 65 years
Signed informed consent
Exclusion of other clinically relevant organic sleep disorders by means of polysomnography (AHI>10/h)

Exclusion criteria

Presence of severe psychiatric comorbidity
Other psychotherapy during the study period
Change of medication used for narcolepsy therapy shortly before the start and during the study period including follow-up measurement. In this case, patients may still complete group therapy, but the data will not be included in the analysis.